United States RNA-Based Vaccines Market Report 2018

United States RNA-Based Vaccines Market Report 2018

1 RNA-Based Vaccines Overview

1.1 Product Overview and Scope of RNA-Based Vaccines

1.2 Classification of RNA-Based Vaccines by Product Category

1.2.1 United States RNA-Based Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States RNA-Based Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3

1.2.4

1.3 United States RNA-Based Vaccines Market by Application/End Users

1.3.1 United States RNA-Based Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Cancer

1.3.3 Diabetes

1.3.4 Tuberculosis

1.3.5 Cardiovascular Diseases

1.3.6 Others

1.4 United States RNA-Based Vaccines Market by Region

1.4.1 United States RNA-Based Vaccines Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West RNA-Based Vaccines Status and Prospect (2013-2025)

1.4.3 Southwest RNA-Based Vaccines Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic RNA-Based Vaccines Status and Prospect (2013-2025)

1.4.5 New England RNA-Based Vaccines Status and Prospect (2013-2025)

1.4.6 The South RNA-Based Vaccines Status and Prospect (2013-2025)

1.4.7 The Midwest RNA-Based Vaccines Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of RNA-Based Vaccines (2013-2025)

1.5.1 United States RNA-Based Vaccines Sales and Growth Rate (2013-2025)

1.5.2 United States RNA-Based Vaccines Revenue and Growth Rate (2013-2025)

2 United States RNA-Based Vaccines Market Competition by Players/Suppliers

2.1 United States RNA-Based Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States RNA-Based Vaccines Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States RNA-Based Vaccines Average Price by Players/Suppliers (2013-2018)

2.4 United States RNA-Based Vaccines Market Competitive Situation and Trends

2.4.1 United States RNA-Based Vaccines Market Concentration Rate

2.4.2 United States RNA-Based Vaccines Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers RNA-Based Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States RNA-Based Vaccines Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States RNA-Based Vaccines Sales and Market Share by Region (2013-2018)

3.2 United States RNA-Based Vaccines Revenue and Market Share by Region (2013-2018)

3.3 United States RNA-Based Vaccines Price by Region (2013-2018)

4 United States RNA-Based Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States RNA-Based Vaccines Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States RNA-Based Vaccines Revenue and Market Share by Type (2013-2018)

4.3 United States RNA-Based Vaccines Price by Type (2013-2018)

4.4 United States RNA-Based Vaccines Sales Growth Rate by Type (2013-2018)

5 United States RNA-Based Vaccines Sales (Volume) by Application (2013-2018)

5.1 United States RNA-Based Vaccines Sales and Market Share by Application (2013-2018)

5.2 United States RNA-Based Vaccines Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States RNA-Based Vaccines Players/Suppliers Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 RNA-Based Vaccines Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Roche

6.2.2 RNA-Based Vaccines Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Sanofi-Aventis

6.3.2 RNA-Based Vaccines Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Abbott Laboratories

6.4.2 RNA-Based Vaccines Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Arrowhead Pharmaceuticals

6.5.2 RNA-Based Vaccines Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Benitec Biopharma

6.6.2 RNA-Based Vaccines Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Calimmune Inc

6.7.2 RNA-Based Vaccines Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Dicerna

6.8.2 RNA-Based Vaccines Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Gradalis

6.9.2 RNA-Based Vaccines Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Quark

6.10.2 RNA-Based Vaccines Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 RXi

6.12 Senesco

6.13 Silence Therapeutics

6.14 Silenseed

6.15 Tekmira

6.16 Alnylam Pharmaceuticals

7 RNA-Based Vaccines Manufacturing Cost Analysis

7.1 RNA-Based Vaccines Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of RNA-Based Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 RNA-Based Vaccines Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States RNA-Based Vaccines Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States RNA-Based Vaccines Sales Volume, Revenue Forecast (2018-2025)

11.2 United States RNA-Based Vaccines Sales Volume Forecast by Type (2018-2025)

11.3 United States RNA-Based Vaccines Sales Volume Forecast by Application (2018-2025)

11.4 United States RNA-Based Vaccines Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of RNA-Based Vaccines

Figure United States RNA-Based Vaccines Market Size (K Units) by Type (2013-2025)

Figure United States RNA-Based Vaccines Sales Volume Market Share by Type (Product Category) in 2017

Figure Type I Product Picture

Figure Type II Product Picture

Figure United States RNA-Based Vaccines Market Size (K Units) by Application (2013-2025)

Figure United States Sales Market Share of RNA-Based Vaccines by Application in 2017

Figure Cancer Examples

Table Key Downstream Customer in Cancer

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Tuberculosis Examples

Table Key Downstream Customer in Tuberculosis

Figure Cardiovascular Diseases Examples

Table Key Downstream Customer in Cardiovascular Diseases

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States RNA-Based Vaccines Market Size (Million USD) by Region (2013-2025)

Figure The West RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States RNA-Based Vaccines Sales (K Units) and Growth Rate (2013-2025)

Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States RNA-Based Vaccines Market Major Players Product Sales Volume (K Units) (2013-2018)

Table United States RNA-Based Vaccines Sales (K Units) of Key Players/Suppliers (2013-2018)

Table United States RNA-Based Vaccines Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States RNA-Based Vaccines Sales Share by Players/Suppliers

Figure 2017 United States RNA-Based Vaccines Sales Share by Players/Suppliers

Figure United States RNA-Based Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States RNA-Based Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States RNA-Based Vaccines Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States RNA-Based Vaccines Revenue Share by Players/Suppliers

Figure 2017 United States RNA-Based Vaccines Revenue Share by Players/Suppliers

Table United States Market RNA-Based Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

Figure United States Market RNA-Based Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2017

Figure United States RNA-Based Vaccines Market Share of Top 3 Players/Suppliers

Figure United States RNA-Based Vaccines Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers RNA-Based Vaccines Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers RNA-Based Vaccines Product Category

Table United States RNA-Based Vaccines Sales (K Units) by Region (2013-2018)

Table United States RNA-Based Vaccines Sales Share by Region (2013-2018)

Figure United States RNA-Based Vaccines Sales Share by Region (2013-2018)

Figure United States RNA-Based Vaccines Sales Market Share by Region in 2017

Table United States RNA-Based Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States RNA-Based Vaccines Revenue Share by Region (2013-2018)

Figure United States RNA-Based Vaccines Revenue Market Share by Region (2013-2018)

Figure United States RNA-Based Vaccines Revenue Market Share by Region in 2017

Table United States RNA-Based Vaccines Price (USD/Unit) by Region (2013-2018)

Table United States RNA-Based Vaccines Sales (K Units) by Type (2013-2018)

Table United States RNA-Based Vaccines Sales Share by Type (2013-2018)

Figure United States RNA-Based Vaccines Sales Share by Type (2013-2018)

Figure United States RNA-Based Vaccines Sales Market Share by Type in 2017

Table United States RNA-Based Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States RNA-Based Vaccines Revenue Share by Type (2013-2018)

Figure Revenue Market Share of RNA-Based Vaccines by Type (2013-2018)

Figure Revenue Market Share of RNA-Based Vaccines by Type in 2017

Table United States RNA-Based Vaccines Price (USD/Unit) by Types (2013-2018)

Figure United States RNA-Based Vaccines Sales Growth Rate by Type (2013-2018)

Table United States RNA-Based Vaccines Sales (K Units) by Application (2013-2018)

Table United States RNA-Based Vaccines Sales Market Share by Application (2013-2018)

Figure United States RNA-Based Vaccines Sales Market Share by Application (2013-2018)

Figure United States RNA-Based Vaccines Sales Market Share by Application in 2017

Table United States RNA-Based Vaccines Sales Growth Rate by Application (2013-2018)

Figure United States RNA-Based Vaccines Sales Growth Rate by Application (2013-2018)

Table Pfizer Basic Information List

Table Pfizer RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Pfizer RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Pfizer RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Roche Basic Information List

Table Roche RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Roche RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Roche RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi-Aventis RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Sanofi-Aventis RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Sanofi-Aventis RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Abbott Laboratories RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Abbott Laboratories RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Abbott Laboratories RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Arrowhead Pharmaceuticals Basic Information List

Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Benitec Biopharma Basic Information List

Table Benitec Biopharma RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Benitec Biopharma RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Benitec Biopharma RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Benitec Biopharma RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Calimmune Inc Basic Information List

Table Calimmune Inc RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Calimmune Inc RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Calimmune Inc RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Calimmune Inc RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Dicerna Basic Information List

Table Dicerna RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Dicerna RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Dicerna RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Dicerna RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Gradalis Basic Information List

Table Gradalis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Gradalis RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Gradalis RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Gradalis RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table Quark Basic Information List

Table Quark RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Quark RNA-Based Vaccines Sales Growth Rate (2013-2018)

Figure Quark RNA-Based Vaccines Sales Market Share in United States (2013-2018)

Figure Quark RNA-Based Vaccines Revenue Market Share in United States (2013-2018)

Table RXi Basic Information List

Table Senesco Basic Information List

Table Silence Therapeutics Basic Information List

Table Silenseed Basic Information List

Table Tekmira Basic Information List

Table Alnylam Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of RNA-Based Vaccines

Figure Manufacturing Process Analysis of RNA-Based Vaccines

Figure RNA-Based Vaccines Industrial Chain Analysis

Table Raw Materials Sources of RNA-Based Vaccines Major Players/Suppliers in 2017

Table Major Buyers of RNA-Based Vaccines

Table Distributors/Traders List

Figure United States RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States RNA-Based Vaccines Price (USD/Unit) Trend Forecast (2018-2025)

Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type in 2025

Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application in 2025

Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Region (2018-2025)

Table United States RNA-Based Vaccines Sales Volume Share Forecast by Region (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume Share Forecast by Region (2018-2025)

Figure United States RNA-Based Vaccines Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources